REGENERON PHARMACEUTICALS, INC.
For the period ended Jun 12, 2026. Filed Apr 24, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Jun 12, 2026 · Filed Apr 24, 2026
Contents
Code of Ethics
The board of directors has adopted a code of business conduct and ethics that applies to all of our employees, officers,
and directors. You can find this code on our website atwww.regeneron.com under the “Governance” heading on the
“Investors & Media” page. We may satisfy the disclosure requirement under Item 5.05 of Form 8-K regarding an
amendment to, or a waiver from, a provision of our code of business conduct and ethics that applies to our principal
executive officer, principal financial officer, principal accounting officer, or controller, or persons performing similar
functions, by posting such information on our website where it is accessible through the same link noted above.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.